CIBC Private Wealth Group
HAE icon

CIBC Private Wealth Group’s Haemonetics HAE Stock Holding History

CIBC Private Wealth Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$82.4K Sell
1,028
-66
-6% -$4.43K ﹤0.01% 1601
2025
Q3 		$53.3K Buy
1,094
+448
+69% +$27.7K ﹤0.01% 1763
2025
Q2 		$48.2K Hold
646
– – ﹤0.01% 1677
2025
Q1 		$36.2K Buy
646
+144
+29% +$9.79K ﹤0.01% 1757
2024
Q4 		$39.2K Buy
502
+57
+13% +$4.58K ﹤0.01% 1765
2024
Q3 		$35.8K Buy
445
+50
+13% +$4.04K ﹤0.01% 1900
2024
Q2 		$33.8K Sell
395
-153
-28% -$13.5K ﹤0.01% 1829
2024
Q1 		$46.5K Buy
+548
New +$43K ﹤0.01% 1712
2018
Q3 		– Sell
-150
Closed -$13K – 1270
2018
Q2 		$13K Hold
150
– – ﹤0.01% 1505
2018
Q1 		$11K Buy
+150
New +$10.3K ﹤0.01% 1508

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CIBC Private Wealth Group's HAE Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Haemonetics (HAE) stake by 6% in Q4 2025, selling an estimated $4.43K and leaving 1,028 shares worth $82.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

CIBC Private Wealth Group first reported a position in HAE in Q1 2018 and has held it in 10 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • CIBC Private Wealth Group held 1,028 shares of Haemonetics worth $82.4K as of Q4 2025.
  • CIBC Private Wealth Group sold 66 Haemonetics shares in Q4 2025, an estimated $4.43K.
  • Haemonetics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1601 holding.
  • CIBC Private Wealth Group first reported a position in Haemonetics in Q1 2018 and has held it in 10 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.